Verastem, Inc.
Verastem, Inc. (0LOV.L) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Verastem, Inc. (0LOV.L), featuring income statements, balance sheets, and cash flow data.
Verastem, Inc. (0LOV.L) Income Statement & Financial Overview
View the income breakdown for Verastem, Inc. 0LOV.L across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | -$9.98M | $0.00 | $10.00M |
| Cost of Revenue | $0.00 | $7000.00 | $0.00 | $6000.00 |
| Gross Profit | $0.00 | -$9.99M | $0.00 | $9.99M |
| Gross Profit Ratio | $0.00 | $1.001 | $0.00 | $1.00 |
| R&D Expenses | $29.15M | $20.81M | $24.75M | $18.06M |
| SG&A Expenses | $15.02M | $10.78M | $12.28M | $10.21M |
| Operating Expenses | $44.17M | $31.58M | $37.03M | $28.27M |
| Total Costs & Expenses | $0.00 | $31.59M | $37.03M | $28.28M |
| Interest Income | $960000.00 | $968000.00 | $831000.00 | $983000.00 |
| Interest Expense | -$192000.00 | $1.15M | $1.15M | $1.14M |
| Depreciation & Amortization | $0.00 | $7000.00 | $7000.00 | $6000.00 |
| EBITDA | -$44.17M | -$63.21M | -$22.81M | -$7.11M |
| EBITDA Ratio | $0.00 | $6.34 | $0.00 | -$0.71 |
| Operating Income | -$44.17M | -$31.59M | -$37.03M | -$18.28M |
| Operating Income Ratio | $0.00 | $3.17 | $0.00 | -$1.83 |
| Other Income/Expenses (Net) | -$7.93M | -$32.78M | $13.06M | $10.02M |
| Income Before Tax | -$52.10M | -$64.37M | -$23.97M | -$8.26M |
| Income Before Tax Ratio | $0.00 | $6.45 | $0.00 | -$0.83 |
| Income Tax Expense | $0.00 | $185000.00 | $0.00 | $0.00 |
| Net Income | -$52.10M | -$64.55M | -$23.97M | -$8.26M |
| Net Income Ratio | $0.00 | $6.47 | $0.00 | -$0.83 |
| EPS | -$1.46 | -$1.33 | -$0.60 | -$0.31 |
| Diluted EPS | -$1.46 | -$1.33 | -$0.60 | -$0.31 |
| Weighted Avg Shares Outstanding | $35.71M | $35.71M | $40.26M | $26.86M |
| Weighted Avg Shares Outstanding (Diluted) | $35.71M | $35.71M | $40.26M | $26.86M |
Over the past four quarters, Verastem, Inc. demonstrated steady revenue growth, increasing from $10.00M in Q2 2024 to $0.00 in Q1 2025. Operating income reached -$44.17M in Q1 2025, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$44.17M, reflecting operational efficiency. Net income rose to -$52.10M, with EPS at -$1.46. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan